• 1
    Cannistra SA,Niloff JM. Cancer of the uterine cervix. N Engl J Med. 1996; 334: 10301038.
  • 2
    Schiffman M,Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med. 2003; 127: 946949.
  • 3
    Sherman ME,Lorincz AT,Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003; 95: 4652.
  • 4
    Wright TCJr.,Cox JT,Massad LS,Carlson J,Twiggs LB,Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003; 189: 295304.
  • 5
    Arbyn M,Buntinx F,Van Ranst M,Paraskevaidis E,Martin-Hirsch P,Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst. 2004; 96: 280293.
  • 6
    Solomon D,Schiffman M,Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001; 93: 293299.
  • 7
    von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer. 2002; 38: 22292242.
  • 8
    Khleif SN,DeGregori J,Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A. 1996; 93: 43504354.
  • 9
    Klaes R,Friedrich T,Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001; 92: 276284.
  • 10
    Klaes R,Benner A,Friedrich T,Ridder R, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002; 26: 13891399.
  • 11
    Sano T,Oyama T,Kashiwabara K,Fukuda T,Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998; 153: 17411748.
  • 12
    Agoff SN,Lin P,Morihara J,Mao C,Kiviat NB,Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 2003; 16: 665673.
  • 13
    Negri G,Vittadello F,Romano F, et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 2004; 445: 616620.
  • 14
    Wang JL,Zheng BY,Li XD,Angstrom T,Lindstrom MS,Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res. 2004; 10: 24072414.
  • 15
    Wang SS,Trunk M,Schiffman M, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004; 13: 13551360.
  • 16
    Nieh S,Chen SF,Chu TY, et al. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol. 2005; 97: 3540.
  • 17
    Sahebali S,Depuydt CE,Boulet GA, et al. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer. 2006; 118: 12541260.
  • 18
    Trunk MJ,Dallenbach-Hellweg G,Ridder R, et al. Morphologic characteristics of p16ink4a-positive cells in cervical cytology samples. Acta Cytol. 2004; 48: 771782.
  • 19
    Wentzensen N,Bergeron C,Cas F,Eschenbach D,Vinokurova S,von Knebel Doeberitz M. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer. 2005; 105: 461467.
  • 20
    Bergeron C,Fagnani F. Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratory. Acta Cytol. 2003; 47: 753761.
  • 21
    Guo M,Hu L,Baliga M,He Z,Hughson MD. The predictive value of p16 (INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004; 122: 894901.
  • 22
    Yoshida T,Fukuda T,Sano T,Kanuma T,Owada N,Nakajima T. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer. 2004; 102: 100108.
  • 23
    Carozzi F,Cecchini S,Confortini M, et al. Role of P16((INK4a)) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer. 2006; 108: 119123.
  • 24
    Bergeron C,Jeannel D,Poveda J,Cassonnet P,Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet.Gynecol. 2000; 95: 821827.
  • 25
    ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003; 188: 13831392. Comment in: Am J Obstet Gynecol. 2003;188:1381-1382.